Provided content expertise (particularly in regards to patents) for a market survey of biomarkers for a variety of select agents. The summation of data will be used as preliminary basis for developing far off handheld detection systems.

 

This study’s goal was to assess the short term feasibility of developing an immunoassay platform for select agents not capable of detection by PCR, such as diseases that move intracellularly or mutate too quickly for efficient primer development.